CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-23 | Iwicki Mark T Director | Sale | −154,894 | $0.81 | $125K | 103,540 |
| 2025-06-24 | Iwicki Mark T Director | Sale | −13,227 | $4.01 | $53K | 258,433 |
| 2025-06-15 | Iwicki Mark T Director | Grant or award | +2,450 | 271,660 | ||
| 2025-06-15 | Iwicki Mark T Director | Grant or award · Stock Option (right to buy) | +5,450 | 5,450 | ||
| 2025-06-03 | Iwicki Mark T Director | Sale | −10,866 | $3.74 | $41K | 269,210 |
| 2025-06-03 | Iwicki Mark T Director | Sale | +10,866 | $3.74 | $41K | 269,210 |
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +22,100 | 285,855 | ||
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −5,779 | $7.63 | $44K | 280,076 |
| 2025-01-06 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +99,500 | 99,500 | ||
| 2024-06-26 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −15,168 | $4.75 | $72K | 263,755 |
| 2024-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −7,392 | $6.09 | $45K | 278,923 |
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +14,300 | 290,854 | ||
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −4,539 | $6.73 | $31K | 286,315 |
| 2024-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +64,500 | 64,500 | ||
| 2023-06-22 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +158,873 | 276,554 | ||
| 2023-06-22 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +211,831 | 211,831 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +71,715 | 117,681 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −5,449 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −7,576 | 0 | ||
| 2023-05-31 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (right to buy) | −12,195 | 0 |
Page 1 of 3 · 44 trades